deltatrials
Completed OBSERVATIONAL NCT02230969

Plegridy Observational Program (POP)

Plegridy™ (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program

Sponsor: Biogen

Updated 19 times since 2017 Last updated: Sep 23, 2022 Started: Nov 12, 2014 Primary completion: Jan 20, 2022 Completion: Jan 20, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Relapsing Forms of Multiple Sclerosis, this trial is completed. The trial is conducted by Biogen and has accumulated 19 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Sep 2017 · 6 months · monthly snapshot~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshot~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Mar 2019 · 7 months · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~May 2020 · 12 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Mar 2022 · 9 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

19 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Sep 2022 — Jul 2024 [monthly]

    Completed

  5. Mar 2022 — Sep 2022 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

Show 14 earlier versions
  1. Jun 2021 — Mar 2022 [monthly]

    Active Not Recruiting

  2. Jan 2021 — Jun 2021 [monthly]

    Active Not Recruiting

  3. May 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  4. May 2019 — May 2020 [monthly]

    Active Not Recruiting

  5. Mar 2019 — May 2019 [monthly]

    Active Not Recruiting

  6. Aug 2018 — Mar 2019 [monthly]

    Active Not Recruiting

  7. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  8. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NANone

  9. Feb 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

  10. Dec 2017 — Feb 2018 [monthly]

    Active Not Recruiting NA

  11. Sep 2017 — Dec 2017 [monthly]

    Active Not Recruiting NA

  12. Mar 2017 — Sep 2017 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  13. Feb 2017 — Mar 2017 [monthly]

    Recruiting NA

  14. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biogen
Data source: Biogen

For direct contact, visit the study record on ClinicalTrials.gov .